apo-ondansetron solution
apotex inc - ondansetron (ondansetron hydrochloride dihydrate) - solution - 4mg - ondansetron (ondansetron hydrochloride dihydrate) 4mg - 5-ht3 receptor antagonists
trimetoprima sulfametoxazol mk forte 160 mg / 800 mg tabletas
corporaciÓn bonima, s.a. de c.v. - trimetoprima - trimetoprima....160.00 mg / sulfametoxazol....800.00 mg
trimetoprima -sulfametoxazol 160-800 mg tabletas
laboratorios la sante s.a.. - trimetoprima - trimetoprima....160.00 mg / sulfametoxazol....800.00 mg
trimetoprima sulfametoxazol mk 40-200mg/ 5ml suspensión oral
corporacion bonima, s.a. de c.v. - trimetoprima - trimetoprima....40.00mg / sulfametoxazol....200.00mg
trimetoprim sulfametoxazol 40 mg-200 mg / 5 ml suspension oral
genfar s.a - trimetoprima - trimetoprima....0.800g / sulfametoxasol....4.000g
trimetoprim-sulfametoxazol - f 160mg/800mg tabletas
genfar, s.a. - trimetoprim - trimetoprim....160,000mg / sulfametoxazol....800,000mg
trimetoprim sulfa ecar suspensión oral
laboratorios ecar s.a. - trimetoprim - trimetoprim....800.0000 mg / sulfametoxasol....4,000.0000 mg
trimetoprim 80 mg/ 5 ml + sulfametoxazol 400 mg/ 5 ml solución inyectable intravenosa por infusión
laboratorios ryan de colombia s.a.s - trimetoprim - trimetoprim....80.00 mg / sulfametoxazol....400.00 mg
metpram metoclopramide hydrochloride 10 mg film coated tablets blister pack
ipca pharma (australia) pty ltd - metoclopramide hydrochloride, quantity: 10 mg - tablet, film coated - excipient ingredients: purified talc; stearic acid; macrogol 6000; pregelatinised maize starch; hypromellose; titanium dioxide; colloidal anhydrous silica; maize starch; microcrystalline cellulose - in adults (20 years and over): as an adjunct to x-ray examination of the stomach and duodenum. to assist in intestinal intubation. to control nausea and vomiting associated with the following conditions: intolerance to essential drugs possessing emetic properties; uraemia; radiation sickness; malignant disease; postoperative vomiting; labour; infectious diseases. there is no clear benefit in motion sickness or other labyrinth disturbances. metoclopramide hydrochloride has been found useful in the management of gastric retention after gastric surgery. metoclopramide hydrochloride may be useful in the treatment of diabetic gastroparesis of mild to moderate severity. once control of diabetes has been established by diet and/or insulin, metoclopramide hydrochloride should be discontinued.,young adults: the use of metoclopramide hydrochloride in patients under 20 years should be restricted to the following situations: severe intractable vomiting of known cause. vomiting associated with radiotherapy and intolerance to cytotoxic drugs. as an aid to gastrointestinal intubation
metpram metoclopramide hydrochloride 5 mg film coated tablets blister pack
ipca pharma (australia) pty ltd - metoclopramide hydrochloride, quantity: 5 mg - tablet, film coated - excipient ingredients: maize starch; pregelatinised maize starch; titanium dioxide; microcrystalline cellulose; macrogol 6000; purified talc; hypromellose; stearic acid; colloidal anhydrous silica - in adults (20 years and over): as an adjunct to x-ray examination of the stomach and duodenum. to assist in intestinal intubation. to control nausea and vomiting associated with the following conditions: intolerance to essential drugs possessing emetic properties; uraemia; radiation sickness; malignant disease; postoperative vomiting; labour; infectious diseases. there is no clear benefit in motion sickness or other labyrinth disturbances. metoclopramide hydrochloride has been found useful in the management of gastric retention after gastric surgery. metoclopramide hydrochloride may be useful in the treatment of diabetic gastroparesis of mild to moderate severity. once control of diabetes has been established by diet and/or insulin, metoclopramide hydrochloride should be discontinued.,young adults: the use of metoclopramide hydrochloride in patients under 20 years should be restricted to the following situations: severe intractable vomiting of known cause. vomiting associated with radiotherapy and intolerance to cytotoxic drugs. as an aid to gastrointestinal intubation